Dr. Poon is a Emeritus and Clinical Professor of Medicine, Oncology and Pediatrics, and Director, Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program. Dr. Poon was head of the Division of Hematology and Hematologic Malignancies in the Department of Medicine (1993-2001) and director of Hematology in the Department of Laboratory Medicine and Pathology, Foothills Hospital (1988-1997). Active in the hematology/hemostasis/ thrombosis research, care and education community nationally and internationally. More than 250 peer-reviewed publications in addition to book chapters and invited articles. Past president of the Canadian Hematology Society (1998-2000) and past president of the Association of Hemophilia Clinic Directors of Canada (1997-1999). Dr. Poon is a distinguished emeritus member of the American Society of Hematology. Since 1993 has been a volunteer for the World Federation of Hemophilia promoting hemophilia care, research and education in China.
Area of Focus
- Hemostasis/thrombosis: long standing research interest
- Recent interest: History of Medicine (i) hemophilia care and hemophilia clinic development in Canada (ii) cancer clinical trials in Canada and its ethics of human dignity framework (with Dr. Frank Stahnisch and Dr. Fedir Razumenko, Department of History).
Summary of Research
- Jackson, S.C., Sinclair, G.D., Cloutier, S., Duan, Z., Rand, M.L. Poon, M-C. Montreal platelet syndrome kindred has type 2B von Willebrand disease with theVWF V1316M mutation Blood 2009;113:3348-3351
- Lee A, Boyd SK, Kline G, Poon M-C. Premature changes in trabecular and cortical microarchitecture results in decreased bone strength in hemophilia. Blood 2015; 125 (13): 2160-2163
- Poon M-C, d’Oiron R, Zotz RB, Bindslev N, Di Minno MND, Di Minno G, for the Glanzmann Thrombasthenia Registry Investigators. The international prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention Haematologica 2015; 100(8):1038-1044
- Poon M-C, d’Oiron R. Alloimmunization in congenital deficiencies of platelet surface glycoproteins: Focus on Glanzmann Thrombasthenia and Bernard-Soulier Syndrome. Seminars in Thrombosis and Hemostasis 2018;44(6):604-614
- Poon, M-C. Factor VIIa (Chapter 63). In “Platelets”, Edition 4, Edited by Michelson AD, Cattaneo M, Frelinger ALI and Newman PJ. New York: Elsevier/Academic Press 2019 March (in press)
Area Of Focus
- Hemostasis/thrombosis: long standing research interest
- Recent interest: History of Medicine (i) hemophilia care and hemophilia clinic development in Canada (ii) cancer clinical trials in Canada and its ethics of human dignity framework (with Dr. Frank Stahnisch and Dr. Fedir Razumenko, Department of History).
Summary Of Research
- Jackson, S.C., Sinclair, G.D., Cloutier, S., Duan, Z., Rand, M.L. Poon, M-C. Montreal platelet syndrome kindred has type 2B von Willebrand disease with theVWF V1316M mutation Blood 2009;113:3348-3351
- Lee A, Boyd SK, Kline G, Poon M-C. Premature changes in trabecular and cortical microarchitecture results in decreased bone strength in hemophilia. Blood 2015; 125 (13): 2160-2163
- Poon M-C, d’Oiron R, Zotz RB, Bindslev N, Di Minno MND, Di Minno G, for the Glanzmann Thrombasthenia Registry Investigators. The international prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention Haematologica 2015; 100(8):1038-1044
- Poon M-C, d’Oiron R. Alloimmunization in congenital deficiencies of platelet surface glycoproteins: Focus on Glanzmann Thrombasthenia and Bernard-Soulier Syndrome. Seminars in Thrombosis and Hemostasis 2018;44(6):604-614
- Poon, M-C. Factor VIIa (Chapter 63). In “Platelets”, Edition 4, Edited by Michelson AD, Cattaneo M, Frelinger ALI and Newman PJ. New York: Elsevier/Academic Press 2019 March (in press)